Ghrelin Improves Endothelial Function in Patients With Metabolic Syndrome

Author:

Tesauro Manfredi1,Schinzari Francesca1,Iantorno Micaela1,Rizza Stefano1,Melina Domenico1,Lauro Davide1,Cardillo Carmine1

Affiliation:

1. From the Dipartimento di Medicina Interna (M.T., M.I., S.R., D.L.), Università di Tor Vergata, and the Divisione di Terapia Medica, Complesso Integrato Columbus (F.S., D.M., C.C.), Università Cattolica del Sacro Cuore, Rome, Italy.

Abstract

Background— Metabolic syndrome importantly accelerates the atherosclerotic process, the earliest event of which is endothelial dysfunction. Ghrelin, a gastric peptide with cardiovascular actions, has been shown to inhibit proatherogenic changes in experimental models. This study therefore investigated whether ghrelin administration might beneficially affect endothelial function in metabolic syndrome. Methods and Results— Endothelium-dependent and -independent vasodilator responses to intra-arterial infusion of increasing doses of acetylcholine and sodium nitroprusside (SNP), respectively, were assessed by strain-gauge plethysmography before and after local administration of human ghrelin (200 μg/min). During saline, the vasodilator response to acetylcholine was significantly blunted ( P =0.008) in patients with metabolic syndrome (n=12, 5 female) compared with controls (n=12, 7 female), whereas the vasodilator response to SNP was not different between groups ( P =0.68). In patients with metabolic syndrome, basal plasma ghrelin was significantly lower than in controls ( P =0.02). In these patients, ghrelin infusion markedly increased intravascular concentrations of the peptide ( P <0.001) and resulted in a potentiation of the vasodilator response to acetylcholine ( P =0.001 versus saline) but not to SNP ( P =0.22). This effect was likely related to enhanced nitric oxide bioavailability because, in a group of patients with metabolic syndrome (n=6, 2 female), ghrelin had no effect on the vasodilator response to acetylcholine ( P =0.78 versus saline) after nitric oxide inhibition by N G -monomethyl- l -arginine. Conclusions— These findings indicate that ghrelin reverses endothelial dysfunction in patients with metabolic syndrome by increasing nitric oxide bioactivity, thereby suggesting that decreased circulating levels of the peptide, such as those found in these patients, might play a role in the pathobiology of atherosclerosis.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3